Author:
Chowdhury Partha S.,Pastan Ira
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference38 articles.
1. Waldmann, T.A. et al. Radioimmunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac. Blood 86 , 4063–4075 (1995).
2. Pai, L.H., Wittes, R., Setser, A., Willingham, M.C., and Pastan, I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med. 2, 350–353 (1996).
3. Maloney, D.G. et al. IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 80, 2188–2195 (1997).
4. Osterborg, A. et al. Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. J. Clin. Oncol. 15, 1567–1574 (1997).
5. Baselga, J., Norton, L., Albanell, J., Kim, Y.M. & Mendelsohn, J. Recombinant humanized anti-HER2 antibody (Herceptin (M)) enhances the antitumor activity of paclitaxel and doxorubincin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 58, 2825–2831 ( 1998).
Cited by
215 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献